Mike is a drug metabolism and pharmacokinetics (DMPK) specialist with over 30 years of drug discovery and development experience gained in the small and large pharma and CRO industry. Over his career, he has helped deliver the integrated DMPK package, including human dose prediction, for 20 candidate molecules. Mike is the Science Director of Discovery DMPK at Charles River and provides scientific and strategic leadership, working closely with clients to progress their integrated drug discovery (IDD) project through lead identification to candidate nomination.